Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Weng, Shu Wen ^a,b   Chen, Bor Chyuan ^c   Wang, Yu Chiao ^d   Liu, Chun Kai ^d   Sun, Mao Feng ^a,d   Chang, Ching Mao ^e,f   Lin, Jaung Geng ^a   Yen, Hung Rong ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Taichung Hospital   (Taiwan)

^c DALIN TZU CHI HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; DANG GUI YIN ZI; HERBACEOUS AGENT; HUANG LIAN JIE DU TANG; JIA WEI XIAO YAO SAN; JING FANG BAI DU SAN; LONG DAN XIEGAN TANG; PRESCRIPTION DRUG; UNCLASSIFIED DRUG; WEN QING YIN; XIANG SHA LIUJUN ZI TANG; XIAO FENG SAN; XUE FU ZHU YU TANG; ZHI BAI DIHUANG WAN;

ACUPUNCTURE; ADULT; AGED; ALLERGIC RHINITIS; ALOPECIA AREATA; ARTICLE; ASTHMA; CHINESE HERB; CHINESE MEDICINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DICTAMNUS; DICTAMNUS DASYCARPUS; FATTY LIVER; FEMALE; FORSYTHIA SUSPENSA; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART DISEASE; HEPATITIS B; HEPATITIS C; HERBAL MEDICINE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; KOCHIA SCOPARIA; LITHOSPERMUM; LITHOSPERMUM ERYTHRORHIZON; LONICERA JAPONICA; MAJOR CLINICAL STUDY; MALE; MOXIBUSTION; MULTIPLE SCLEROSIS; NATIONAL HEALTH INSURANCE; NEOPLASM; PAEONIA LACTIFLORA; PAEONIA SUFFRUTICOSA; PEMPHIGOID; PEMPHIGUS; POPULATION RESEARCH; PRESCRIPTION; PSORIASIS; REHMANNIA GLUTINOSA; RHEUMATOID ARTHRITIS; SALVIA MILTIORRHIZA; SARSAPARILLA; SLEEP DISORDER; SMILAX GLABRA; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TRAUMATOLOGY; TUBERCULOSIS; URBAN AREA; VITILIGO; WESTERN MEDICINE; WHITE COLLAR WORKER;

EID: 84994443306     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3164105     Document Type: Article

References (51)

1. R. Parisi, D. P. Symmons, C. E. Griffiths, D. M. Ashcroft, and Identification and Management of Psoriasis and Associated Comorbidi Ty (IMPACT) Project Team, "Global epidemiology of psoriasis: a systematic review of incidence and prevalence," The Journal of Investigative Dermatology, vol. 133, pp. 377-385, 2013.
2. T.-F. Tsai, T.-S. Wang, S.-T. Hung et al., "Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan," Journal of Dermatological Science, vol. 63, no. 1, pp. 40-46, 2011.
3. J. Vanderpuye-Orgle, Y. Zhao, J. Lu et al., "Evaluating the economic burden of psoriasis in the United States," Journal of the American Academy of Dermatology, vol. 72, no. 6, pp. 961.e5-967.e5, 2015.
4. K.-C. Chen, S.-T. Hung, C.-W. W. Yang, T.-F. Tsai, and C.-H. Tang, "The economic burden of psoriatic diseases in Taiwan," Journal of Dermatological Science, vol. 75, no. 3, pp. 183-189, 2014.
5. W.-H. Boehncke and M. P. Schön, "Psoriasis," The Lancet, vol. 386, no. 9997, pp. 983-994, 2015.
6. L. Barnes, G. Kaya, and V. Rollason, "Topical corticosteroid-induced skin atrophy: a comprehensive review," Drug Safety, vol. 38, no. 5, pp. 493-509, 2015.
7. J. G. Schlager, S. Rosumeck, R. N. Werner et al., "Topical treatments for scalp psoriasis," The Cochrane Database of Systematic Reviews, no. 2, Article ID CD009687, 2016.
8. K. Papp, J. C. Cather, L. Rosoph et al., "Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial," The Lancet, vol. 380, no. 9843, pp. 738-746, 2012.
9. E. Archier, S. Devaux, E. Castela et al., "Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review," Journal of the European Academy of Dermatology and Venereology, vol. 26, no. 3, pp. 22-31, 2012.
10. R. Conway, C. Low, R. J. Coughlan, M. J. O'Donnell, and J. J. Carey, "Risk of liver injury among methotrexate users: a metaanalysis of randomised controlled trials," Seminars in Arthritis and Rheumatism, vol. 45, no. 2, pp. 156-162, 2015.
11. A. Maza, H. Montaudié, E. Sbidian et al., "Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis," Journal of the European Academy of Dermatology and Venereology, vol. 25, supplement 2, pp. 19-27, 2011.
12. O. D. van Cranenburgh, J. de Korte, M. A. G. Sprangers, M. A. de Rie, and E.M. A. Smets, "Satisfaction with treatment among patients with psoriasis: a web-based survey study," The British Journal of Dermatology, vol. 169, no. 2, pp. 398-405, 2013.
13. J.-F. Lin, P.-H. Liu, T.-P. Huang et al., "Characteristics and prescription patterns of traditional chinese medicine in atopic dermatitis patients: ten-year experiences at a medical center in taiwan," Complementary Therapies in Medicine, vol. 22, no. 1, pp. 141-147, 2014.
14. C.-Y. Huang, W.-Y. Lai, M.-F. Sun et al., "Prescription patterns of traditional Chinesemedicine for peptic ulcer disease in Taiwan: a nationwide population-based study," Journal of Ethnopharmacology, vol. 176, pp. 311-320, 2015.
15. M.-C. Huang, F.-T. Pai, C.-C. Lin et al., "Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study," Journal of Ethnopharmacology, vol. 176, pp. 9-16, 2015.
16. A. L. Lee, B. C. Chen, C. H. Mou, M. F. Sun, and H. R. Yen, "Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwaneseregistry, cohort study," Medicine, vol. 95, no. 3, Article IDe2536, 2016.
17. A. S.-Y. Lien, Y.-D. Jiang, C.-H. Mou, M.-F. Sun, B.-S. Gau, and H.-R. Yen, "Integrative traditional Chinese medicine therapy reduces the risk of diabetic ketoacidosis in patients with type 1 diabetes mellitus," Journal of Ethnopharmacology, vol. 191, pp. 324-330, 2016.
18. H.-R. Yen, Y.-Y. Chen, T.-P. Huang et al., "Prescription patterns of Chinese herbal products for patients with uterine fibroid in Taiwan: a nationwide population-based study," Journal of Ethnopharmacology, vol. 171, pp. 223-230, 2015.
19. T. Fleischer, T.-T. Chang, J.-H. Chiang, C.-M. Chang, C.-Y. Hsieh, and H.-R. Yen, "Adjunctive Chinese Herbal Medicine therapy improves survival of patients with chronic myeloid leukemia: a nationwide population-based cohort study," Cancer Medicine, vol. 5, no. 4, pp. 640-648, 2016.
20. H. R. Yen, W. Y. Lai, C. H. Muo, and M. F. Sun, "Characteristics of traditional Chinesemedicine use in pediatric cancer patients: a nationwide, retrospective, Taiwanese-registry, populationbased study," Integrative Cancer Therapies, 2016.
21. C. S. Zhang, L. Yang, A. L. Zhang et al., "Is oral Chinese herbal medicine beneficial for psoriasis vulgaris? A meta-analysis of comparisons with acitretin," The Journal of Alternative and Complementary Medicine, vol. 22, no. 3, pp. 174-188, 2016.
22. J. J. Yu, C. S. Zhang, A. L. Zhang, B. May, C. C. Xue, and C. Lu, "Add-on effect of Chinese herbalmedicine bath to phototherapy for psoriasis vulgaris: a systematic review," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 673078, 14 pages, 2013.
23. Y.-K. Lin, L.-C. See, Y.-H. Huang et al., "Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial," Phytomedicine, vol. 21, no. 7, pp. 1015-1020, 2014.
24. Y. Yan, W. Liu, P. Andres et al., "Exploratory clinical trial to evaluate the efficacy of a topical traditional Chinese herbal medicine in psoriasis vulgaris," Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 719641, 6 pages, 2015.
25. E. T. Landis, S. A. Davis, S. R. Feldman, and S. Taylor, "Complementary and alternative medicine use in dermatology in the United States," Journal of Alternative and Complementary Medicine, vol. 20, no. 5, pp. 392-398, 2014.
26. NHIA, National Health Insurance Annual Report 2015-2016, National Health Insurance Administration, Ministry of Health and Welfare, Taipei, Taiwan, 2015.
27. C. C. Chang, Y. C. Lee, C. C. Lin et al., "Characteristics of traditional chinese medicine usage in patients with stroke in taiwan: a nationwide population-based study," Journal of Ethnopharmacology, vol. 186, pp. 311-321, 2016.
28. D. Bensky, S. Clavey, and E. Stoger, Chinese Herbal Medicine: Materia Medica, Eastland Press, Seattle, Wash, USA, 3rd edition, 2004.
29. V. Scheid, D. Bensky, A. Ellis, and R. Barolet, Chinese Herbal Medicine: Formulas & Strategies, Eastland Press, 2009.
30. K. Chan, D. Shaw, M. S. J. Simmonds et al., "Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica," Journal of Ethnopharmacology, vol. 140, no. 3, pp. 469-475, 2012.
31. C. M. Chang, H. T. Chu, Y. H. Wei et al., "The core pattern analysis on Chinese herbal medicine for Sjogren's syndrome: a nationwide population-based study," Scientific Reports, vol. 5, article 9541, 2015.
32. C.-C. Shih, C.-C. Liao, Y.-C. Su, C.-C. Tsai, and J.-G. Lin, "Gender differences in traditional chinese medicine use among adults in Taiwan," PLoS ONE, vol. 7, no. 4, Article ID e32540, 2012.
33. L.-T. Kao, K.-H. Wang, H.-C. Lin, H.-C. Li, S. Yang, and S.-D. Chung, "Use of health care services by patients with psoriasis: a population-based study," The British Journal of Dermatology, vol. 172, no. 5, pp. 1346-1352, 2015.
34. E. Ben-Arye, M. Ziv, M. Frenkel, I. Lavi, and D. Rosenman, "Complementary medicine and psoriasis: linking the patient's outlook with evidence-based medicine," Dermatology, vol. 207, no. 3, pp. 302-307, 2003.
35. G.-W. Kim, J.-M. Park, H.-W. Chin et al., "Comparative analysis of the use of complementary and alternative medicine by Korean patients with and rogenetic alopecia, atopic dermatitis and psoriasis," Journal of the European Academy of Dermatology and Venereology, vol. 27, no. 7, pp. 827-835, 2013.
36. P.-S. Chien, Y.-F. Tseng, Y.-C. Hsu, Y.-K. Lai, and S.-F. Weng, "Frequency and pattern of Chinese herbal medicine prescriptions for urticaria in Taiwan during 2009: analysis of the national health insurance database," BMC Complementary and Alternative Medicine, vol. 13, article 209, 2013.
37. H. Yeung, J. Takeshita, N. N. Mehta et al., "Psoriasis severity and the prevalence of majormedical comorbidity: a populationbased study," JAMA Dermatology, vol. 149, no. 10, pp. 1173-1179, 2013.
38. H. Mori, M. Fuchigami, N. Inoue, H. Nagai, A. Koda, and I. Nishioka, "Principle of the bark of Phellodendron amurense to suppress the cellular immune response," Planta Medica, vol. 60, no. 5, pp. 445-449, 1994.
39. H.-M. Cheng, L.-C. Chiang, Y.-M. Jan, G.-W. Chen, and T.-C. Li, "The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial," International Archives of Allergy and Immunology, vol. 155, no. 2, pp. 141-148, 2011.
40. K. Shichijo and H. Saito, "Effect of Chinese herbal medicines and disodium cromoglycate on IgE-dependent histamine release from mouse cultured mast cells," International Journal of Immunopharmacology, vol. 19, no. 11-12, pp. 677-682, 1998.
41. X. K. Gao, K. Fuseda, T. Shibata, H. Tanaka, N. Inagaki, and H. Nagai, "Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice," Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 191-199, 2005.
42. F.-P. Chen, Y.-Y. Kung, Y.-C. Chen et al., "Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan," Journal of Ethnopharmacology, vol. 117, no. 1, pp. 84-91, 2008.
43. F.-P. Chen, M.-S. Jong, Y.-C. Chen et al., "Prescriptions of Chinese herbalmedicines for insomnia in Taiwan during 2002," Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 236341, 9 pages, 2011.
44. M. A. Gupta, F. C. Simpson, and A. K. Gupta, "Psoriasis and sleep disorders: a systematic review," Sleep Medicine Reviews, vol. 29, pp. 63-75, 2016.
45. H. Kim, M. Kim, H. Kim, G. San Lee, W. G. An, and S. I. Cho, "Anti-inflammatory activities of Dictamnus dasycarpus Turcz., root bark on allergic contact dermatitis induced by dinitrofluorobenzene in mice," Journal of Ethnopharmacology, vol. 149, no. 2, pp. 471-477, 2013.
46. H.-Y. Han, M. H. Ryu, G. Lee et al., "Effects of Dictamnus dasycarpus Turcz., root bark on ICAM-1 expression and chemokine productions in vivo and vitro study," Journal of Ethnopharmacology, vol. 159, pp. 245-252, 2015.
47. J.-Y. Kee, A. Inujima, T. Andoh et al., "Inhibitory effect of Moutan Cortex aqueous fraction on mast cell-mediated allergic inflammation," Journal of Natural Medicines, vol. 69, no. 2, pp. 209-217, 2015.
48. C. S. Zhang, J. J. Yu, S. Parker et al., "Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review," International Journal of Dermatology, vol. 53, no. 11, pp. 1305-1318, 2014.
49. Y. Xu, X. Xu, X. Gao, H. Chen, and L. Geng, "Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway," International Immunopharmacology, vol. 19, no. 2, pp. 327-333, 2014.
50. Y. Y. Choi, M. H. Kim, J. Y. Lee, J. Hong, S.-H. Kim, and W. M. Yang, "Topical application of Kochia scoparia inhibits the development of contact dermatitis in mice," Journal of Ethnopharmacology, vol. 154, no. 2, pp. 380-385, 2014.
51. Z. Sui, L. Li, B. Liu et al., "Optimum conditions for Radix Rehmanniae polysaccharides by RSM and its antioxidant and immunity activity in UVB mice," Carbohydrate Polymers, vol. 92, no. 1, pp. 283-288, 2013.